Pharmafile Logo
Pharmafocus logo
Advanced Search

financial results

Showing 15 posts of 19 posts found.

finance

Sanofi lowers Q3 sales figures from 2015

October 13, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Cipro, Plavix, Sanofi, financial results

Sanofi lowered its aggregate sales figure for Q3 2016 from €9.59 billion to €9.46 billion ahead of the release of …

News
shutterstock_138095450

Valeant stock rises despite weak Q2 results

August 10, 2016
Research and Development, Sales and Marketing Valeant, financial results

Valeant Pharmaceuticals’ share price in pre-market trading has risen 7.44% to $24.12 in the wake of its Q2 results announcement. …

News
mr058666-web

Merck Q2 results beat analyst estimates

August 4, 2016
Medical Communications, Sales and Marketing Merck, financial results

Germany pharmaceutical firm Merck has announced its fiscal results for Q2 2016, beating analyst estimates with earnings before interest, taxes, …

News
amgen_hq

Amgen raises 2016 outlook after Q1 earnings boost

April 29, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Enbrel, etanercept, financial results, financials, sales rise

Amgen (NASDAQ: AMGN) has upgraded their 2016 outlook after posting an increase of 10% in revenues for the first quarter …

News

Pfizer revenues down, but above expectations

February 3, 2016
Research and Development, Sales and Marketing Ian Read, Pfizer, financial results, income, profits, revenue, sales

Pfizer’s revenues took a hit from generic competition on former blockbusters, but the world’s new largest drugmaker still managed to …

News
Joseph Jimenez

Novartis braces for cuts after mixed 2015 performance

January 28, 2016
Sales and Marketing Novartis, financial results, revenue, sales

Net sales at Novartis fell by 5% in 2015 – prompting the company to make billion-dollar changes to its business …

News

Johnson & Johnson hit by fall in 2015 sales

January 27, 2016
Research and Development, Sales and Marketing Janssen, Johnson and Johnson, financial results, revenue, sales

Full year sales at the healthcare giant Johnson & Johnson fell by 6% in 2015, to just over $70 billion, …

News
new Merck sign

Merck achieves 7% sales growth in Q3 2015

November 12, 2015
Sales and Marketing Merck, Rebif, financial results

German pharma group Merck has earned a 7% bump in its sales, and a 10% boost in earnings before deductions, …

News
dollar-544956_1280

Top 5 pharma companies’ Q3 results

November 6, 2015
Medical Communications, Sales and Marketing financial results, revenue, sales

The leading pharma players have been able to report largely positive financial results to their shareholders in the third quarter …

Feature
astrazeneca image

AstraZeneca acquires ZS Pharma for $2.7bn, announces Q3 results

November 6, 2015
Medical Communications AstraZeneca, M&A, MA, ZS Pharma, ZS-9, acquisitions, financial results, hyperkalaemia, mergers

AstraZeneca has announced its acquisition of ZS Pharma for an all-cash total of $2.7 billion. In the latest mega-money deal …

News
GSK logo

GSK plots return to growth with launch of 20 new drugs by 2020

November 4, 2015
Research and Development, Sales and Marketing GSK, Sir Andrew Witty, financial results, product pipeline

GSK has set out plans to boost its flagging performance with the launch of up to 20 new drugs by …

News
Andrew Witty GSK

Pfizer approached GSK for takeover before Allergan

November 4, 2015
Research and Development, Sales and Marketing Allergan, GSK, Pfizer, financial results, product pipeline

Pfizer had a takeover approach rejected by fellow pharma giant GlaxoSmithKline, before turning its attentions to Allergan, it has emerged. …

News
Merck image

Sales up at MSD while Keytruda hits survival target in late-stage trial

October 28, 2015
Research and Development, Sales and Marketing MSD, Merck, financial results, keytruda, pembrolizumab

Worldwide sales at MSD were $10.1 billion in the third quarter of 2015, a 4% increase after accounting for the …

News
Severin Schwan

Roche buoyed by 6% sales growth

October 22, 2015
Sales and Marketing Roche, financial results

Roche has reported strong sales growth for the first nine months of 2015 and revised its sales outlook to reflect …

News
biogen_logo

Revenues up at Biogen – but job losses planned

October 22, 2015
Biogen, financial results, job losses, redundancies

Despite lower than predicted sales of its top-selling products, Biogen has achieved $2.8 billion in revenues in the third quarter …

News

Latest content

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023

Arcturus Therapeutics gains FDA ODD for cystic fibrosis treatment

November 28, 2023

Sanofi and Regeneron share results from phase 3 trial for Dupixent as COPD treatment

November 27, 2023

GSK shares results from phase 3 trial for Blenrep as multiple myeloma treatment

November 27, 2023

Alladapt Immunotherapeutics gains FDA Fast Track Designation for ADP101 as food allergy treatment

November 24, 2023